Ergothioneine vs Glutathione
Two antioxidants with a 'declines with age, so restore it' pitch — one a diet-derived amino acid with strong observational data and zero outcome trials, the other with a real trial showing supplementation raises the body's own stores.
Short answer
The evidence gap decides this one. Glutathione has human clinical data behind it, while ergothioneine has only preclinical or minimal evidence, resting mostly on animal or lab work. Someone focused on antioxidant support, detox and anti-aging has trial data to go on with glutathione; ergothioneine, marketed for general antioxidant support and healthy aging, is still an early-research option.
Ergothioneine
ERGO, the 'longevity vitamin'
A diet-derived amino acid with a dedicated transporter that concentrates it in mitochondria-rich tissue, and strong observational associations between blood levels and healthy aging — but no completed outcome RCT tests supplementation itself.
Full Ergothioneine evidence reviewGlutathione
GSH
Oral glutathione raises body stores in a 6-month RCT (reverses on stopping); but longevity/detox claims are unproven, skin-lightening is modest, and IV is the least-evidenced route.
Full Glutathione evidence reviewErgothioneine vs Glutathione: head to head
- FDA status / approved use
Ergothioneine
Sold as a supplement; a diet-derived nutrientGlutathione
Sold as a supplement; some regulators have warned against off-label IV use for skin-whitening- Marketed for
Ergothioneine
General antioxidant support, healthy agingGlutathione
Antioxidant, detox, anti-aging, skin- Outcome areas
Ergothioneine
Mitochondrial / cellular energy; Longevity / lifespanGlutathione
Liver / detox; Skin / hair; Longevity / lifespan- Evidence grade
Ergothioneine
Preclinical / minimalGlutathione
Clinical data- How it works
Ergothioneine
Antioxidant concentrated in tissues by a dedicated transporter, OCTN1Glutathione
The main antioxidant inside cells; neutralizes reactive oxygen species- Route and dosing
Ergothioneine
Oral supplement; also obtained from food, mostly mushroomsGlutathione
Oral capsule daily, or intravenous infusion at clinics- Headline human result
Ergothioneine
Observational only: each SD higher plasma level tracked with an overall mortality hazard ratio of 0.86 in a 3,236-adult cohortGlutathione
Body glutathione rose roughly 30 to 35% on 1000 mg/day in a 6-month RCT of 54 adults; biomarkers only- Strongest evidence
Ergothioneine
Cheah & Halliwell 2018 review, IUBMB Life. Little or no controlled human outcome data for the marketed useErgothioneine evidence reviewPubMed 30322941Glutathione
Oral RCT, Eur J Nutr 2015Glutathione evidence reviewPubMed 24791752- Key safety signal
Ergothioneine
Safe over short periods in small studies; no long-term outcome trialsGlutathione
IV safety data inadequate; Stevens-Johnson syndrome, thyroid and kidney problems reported, mostly with IV whitening use- How it is obtained
Ergothioneine
Over the counter as a dietary supplementGlutathione
Over the counter as a dietary supplement
| Ergothioneine | Glutathione | |
|---|---|---|
| FDA status / approved use | Sold as a supplement; a diet-derived nutrient | Sold as a supplement; some regulators have warned against off-label IV use for skin-whitening |
| Marketed for | General antioxidant support, healthy aging | Antioxidant, detox, anti-aging, skin |
| Outcome areas | Mitochondrial / cellular energy; Longevity / lifespan | Liver / detox; Skin / hair; Longevity / lifespan |
| Evidence grade | Preclinical / minimal | Clinical data |
| How it works | Antioxidant concentrated in tissues by a dedicated transporter, OCTN1 | The main antioxidant inside cells; neutralizes reactive oxygen species |
| Route and dosing | Oral supplement; also obtained from food, mostly mushrooms | Oral capsule daily, or intravenous infusion at clinics |
| Headline human result | Observational only: each SD higher plasma level tracked with an overall mortality hazard ratio of 0.86 in a 3,236-adult cohort | Body glutathione rose roughly 30 to 35% on 1000 mg/day in a 6-month RCT of 54 adults; biomarkers only |
| Strongest evidence | Cheah & Halliwell 2018 review, IUBMB Life. Little or no controlled human outcome data for the marketed useErgothioneine evidence reviewPubMed 30322941 | Oral RCT, Eur J Nutr 2015Glutathione evidence reviewPubMed 24791752 |
| Key safety signal | Safe over short periods in small studies; no long-term outcome trials | IV safety data inadequate; Stevens-Johnson syndrome, thyroid and kidney problems reported, mostly with IV whitening use |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
- Preclinical / minimal:
- Evidence is largely animal, in-vitro, or anecdotal. Little or no controlled human outcome data for the marketed use.
Our verdict
Glutathione has the more direct human evidence: a six-month RCT shows oral supplementation genuinely raises the body's own glutathione stores, though levels drift back after stopping and no trial shows a disease or aging outcome. Ergothioneine's case is entirely observational — blood levels track with healthier aging in cohort studies — but no completed trial has tested whether supplementing it changes anything. Neither has been compared directly.
Ergothioneine fits if
You're drawn to the epidemiological signal and want the compound with a dedicated cellular transporter concentrating it in mitochondria-rich tissue.
Glutathione fits if
You want the compound with actual interventional human data, even though it only measures a biomarker — and consider the cheaper glycine+NAC precursor route first.
Ergothioneine vs Glutathione: common questions
- Is either ergothioneine or glutathione FDA-approved?
- No. Ergothioneine is sold as a supplement; a diet-derived nutrient. Glutathione is sold as a supplement; some regulators have warned against off-label IV use for skin-whitening.
- Which has stronger human evidence, ergothioneine or glutathione?
- Glutathione. It has human clinical data (key source: Oral RCT, Eur J Nutr 2015), while ergothioneine has only preclinical or minimal evidence (key source: Cheah & Halliwell 2018 review, IUBMB Life).
- What are the main safety concerns with ergothioneine and glutathione?
- Ergothioneine is safe over short periods in small studies; no long-term outcome trials. For glutathione, watch for inadequate IV safety data; Stevens-Johnson syndrome, thyroid and kidney problems reported, mostly with IV whitening use.
Key studies behind each
Ergothioneine
- Ames BN (2018). Prolonging healthy aging: Longevity vitamins and proteins. Proc Natl Acad Sci U S A. PubMed 30322941
- Gründemann D, Harlfinger S, Golz S, Geerts A, et al. (2005). Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A. PubMed 15795384
- Paul BD, Snyder SH (2010). The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. PubMed 19911007
- Smith E, Ottosson F, Hellstrand S, Ericson U, et al. (2020). Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart. PubMed 31672783
Glutathione
- Richie JP Jr, Nichenametla S, Neidig W, et al. (2015). Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. PubMed 24791752
- Sekhar RV, Patel SG, Guthikonda AP, et al. (2011). Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. PubMed 21795440
- Sarkar R, Devadasan S, Choubey V. (2025). Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. PubMed 39444151
- Davids LM, van Wyk JC, Khumalo NP. (2016). Intravenous glutathione for skin lightening: Inadequate safety data. S Afr Med J. PubMed 27499402
The full evidence reviews
- Ergothioneine: the mushroom-derived “longevity vitamin,” assessed
A diet-derived antioxidant with its own transporter and encouraging epidemiology — but no outcome trials. A straight read of what the evidence supports and where it stops.
Updated August 2026
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
Updated August 2026